newsfilter
← Latest News
GlobeNewswire·

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders

TORONTO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE:MSET) (FSE: 9DF) (OTCQB:MSSTF) ("Mindset" or the "Company"), a drug discovery and development company focused on creating novel, optimized, next-generation psychedelic and non-psychede